logo

Vertex Pharmaceuticals Inc. (VRTX)



Trade VRTX now with
  Date
  Headline
2/14/2019 9:09:28 AM Vertex Reports Positive Phase 3 Study For Tezacaftor/Ivacaftor Combination In Children Aged 6-11 Years With CF
2/5/2019 4:05:57 PM Vertex Pharma Q4 EPS $5.97 Vs. $0.39 Year Ago
1/28/2019 9:22:14 AM Vertex: Health Canada Grants Market Authorization For KALYDECO In Children With Certain Mutations In CFTR Gene
1/23/2019 4:06:07 PM Vertex Says Ian Smith Terminated As COO And Interim CFO
1/21/2019 4:02:26 AM Vertex:EC Oks ORKAMBI For Treatment Of Children With Cystic Fibrosis Aged 2 -5 Yrs Old With Most Common Form Of Disease
1/4/2019 8:16:21 AM X-Chem Announce Expansion Of Its Collaboration With Vertex
1/4/2019 7:01:24 AM CRISPR Therapeutics, Vertex Announce FDA Fast Track Designation For CTX001 For Treatment Of Sickle Cell Disease
1/3/2019 8:09:56 AM Vertex, Arbor Biotechnologies Enter Strategic Research Collaboration
12/18/2018 8:33:37 AM Vertex Reports Positive Results Of Phase 2 Study Of Investigational NaV1.8 Inhibitor VX-150
12/13/2018 8:01:59 AM Vertex Pharma: Health Canada Grants Market Authorization For ORKAMBI
11/29/2018 3:02:45 AM Vertex Reports European Commission Approval For KALYDECO